Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Atrium Therapeutics, Inc.

NASDAQ: RNA · Life Sciences · 6 alerts · CIK 2093101

Atrium Therapeutics, Inc. stories on ALFA USA NewsRead the news →
Share price
$6.43Close, Nov 16
Market cap
$139M
Shares outstanding
21.57MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Atrium Therapeutics, Inc. filings on SEC EDGAR ↗

6:18 AM ET 8-K/A
Capital Raise

Atrium Therapeutics Capital Raise

Atrium Therapeutics filed an amendment to correct the post-offering share count following a PIPE transaction involving 5,170,384 shares of common stock and pre-funded warrants for 1,134,930 shares. The company expects to have 21,571,507 shares outstanding after the closing of the offering and the settlement of spin-off related equity awards.

Counterparty
PIPE Investors
6:52 AM ET 8-K
Capital Raise

Atrium Therapeutics Capital Raise of $50M

Atrium Therapeutics entered into a securities purchase agreement for a $50 million private placement (PIPE) involving the sale of 5,170,384 common shares and pre-funded warrants for 1,134,930 shares. The offering was priced at $7.93 per share and included participation from several institutional investors. Proceeds will be used to fund the development of lead product candidates and extend the company's cash runway through 2028.

Value
$50M
Counterparty
Sirenia Capital Management LP, Aberdeen Investments, Montanova, Sessa Capital, Casdin Capital

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.